Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorKekeçoğlu, Aybüke
dc.contributor.authorDalar, Levent
dc.contributor.authorOmaygenç, Derya Özden
dc.contributor.authorArpınar Yiğitbaş, Burcu
dc.contributor.authorÖzenç, Ecder
dc.contributor.authorKoşar, Filiz
dc.date.accessioned2016-05-11T08:37:08Z
dc.date.available2016-05-11T08:37:08Z
dc.date.issued2015
dc.identifier.citationKekecoglu A, Dalar L, Omaygenc DO, Arpinar Yigitbas A, Ozenc E, Kosar F. Intensive care in cases with thoracic and extrathoracic malignant solid tumours: Indications and survival. Pneumon. 2015. 28(3); 222-229en_US
dc.identifier.issn1105-848X
dc.identifier.urihttps://hdl.handle.net/11446/954en_US
dc.identifier.urihttp://www.pneumon.org/en_US
dc.descriptionİstanbul Bilim Üniversitesi, Tıp Fakültesi.en_US
dc.description.abstractAIM: The patients with thoracic and extra-thoracic solid organ tumours hospitalized in the intensive care unit (ICU) were retrospectively analyzed and the effects of their ICU stays on survival rates were investigated. METHODS: Medical files of the patients hospitalized in the adult ICUs between January 2010 and September 2013 were retrospectively investigated. ICU stays of the cases with solid organ tumours were evaluated and survival related factors were analyzed. The correlation between available parametres and survival rates was analyzed. RESULTS: A total of 87 patients (74 males) with a mean age of 64.07 ± 11.90 years were included in the study. The cases were divided into 2 groups as those with thoracic (n = 52; 59.8%) and extrathoracic (n = 35; 40.2%) malignancies. Thoracic malignancies were divided within themselves into two subgroups as SCLC (n = 11; 21.2%) and NSCLC (n = 41; 78.8%) and their survival rates were compared. Respiratory failure (n = 35; 40.2%), respiratory failure and additional indications (n = 37; 42.5%) and other indications (n = 15; 17.2%) were main indications. Mean duration of ICU stays was 12.95 ± 16.48 days (range 1-105). Fifty (57.5%) cases died, 6 (6.9%) patients transferred to another center and 31 cases (35.6%) were discharged. Hospitalization times of the cases with respect to mortality rates were significantly different (p = 0.014). Mean survival was 6.78 ± 1.81 months and six month-survival rate was 29.7%. CONCLUSION: Treatment of patients with thoracic and extra-thoracic solid organ tumours in the ICU increases their survivals; however, admission of cancer patients into an ICU should be based on certain objective criteria.en_US
dc.language.isoengen_US
dc.publisherHellenic Thoracic Society and amp, Hellenic Bronchologic Societyen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectextrathoracic malignant tumoursen_US
dc.subjectlung canceren_US
dc.subjectprognosisen_US
dc.subjectsurvivalen_US
dc.titleIntensive care in cases with thoracic and extrathoracic malignant solid tumours: Indications and survivalen_US
dc.typearticleen_US
dc.relation.journalPneumonen_US
dc.departmentDBÜ, Tıp Fakültesien_US
dc.identifier.issue3
dc.identifier.volume28
dc.identifier.startpage222
dc.identifier.endpage229
dc.contributor.authorIDTR32738en_US
dc.relation.publicationcategoryBelirsizen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster